Central Nervous System Pharmacology Practice Questions

Q: Sumatriptan is used in which of the following conditions?

Migraine. **Explanation:** **Sumatriptan** is the prototype of the "Triptan" class of drugs, which are the first-line agents for the **abortive (acute) treatment of moderate-to-severe migraine attacks.** [1], [2] **Why Migraine is Correct:** The pathophysiology of migraine involves the vasodilation of intracranial blood vessels and the release of pro-inflammatory neuropeptides (like CGRP) from trigeminal nerve endings. Sumatriptan acts as a **selective 5-HT$_{1B/1D}$ receptor agonist**. [2] 1. **5-HT$_{1B}$ stimulation** causes vasoconstriction of dilated cranial vessels. [2] 2. **5-HT$_{1D}$ stimulation** acts presynaptically on trigeminal nerve terminals to inhibit the release of inflammatory peptides. [1], [2] **Why Other Options are Incorrect:** * **Mania & Schizophrenia:** These conditions are primarily associated with dysregulation of Dopamine and Glutamate. They are treated with mood stabilizers (Lithium) and antipsychotics (D2 blockers), respectively. Sumatriptan has no clinical role in dopamine modulation. * **Depression:** While depression involves Serotonin, it is managed by increasing synaptic serotonin levels (SSRIs/SNRIs) or targeting 5-HT$_2$ receptors. Sumatriptan does not cross the blood-brain barrier effectively enough to act as an antidepressant and its receptor profile is too specific for vascular/trigeminal sites. [1] **High-Yield Clinical Pearls for NEET-PG:** * **Route of Administration:** Sumatriptan has low oral bioavailability (approx. 15%). Subcutaneous injection is the fastest-acting route. * **Contraindications:** Because they cause vasoconstriction, Triptans are strictly contraindicated in patients with **Ischemic Heart Disease (CAD)**, Prinzmetal angina, and uncontrolled hypertension. * **Other Uses:** Sumatriptan is also the drug of choice for acute attacks of **Cluster Headache**. * **Adverse Effect:** "Triptan sensations" (chest tightness or pressure) are common but usually non-cardiac in origin.

Q: Which mood stabilizer is used in the management of trigeminal neuralgia?

Carbamazepine. **Explanation:** **Carbamazepine (Option A)** is the drug of choice for the management of **Trigeminal Neuralgia**. While primarily classified as an anticonvulsant and used as a mood stabilizer in Bipolar Disorder, its mechanism involves blocking **use-dependent voltage-gated sodium channels**. This action stabilizes neuronal membranes and inhibits the repetitive firing of the trigeminal nerve, providing relief from the characteristic "electric-shock" pain. **Analysis of Incorrect Options:** * **Valproate (Option B):** Though a broad-spectrum anticonvulsant and mood stabilizer, it is not the first-line treatment for trigeminal neuralgia. It is more commonly used for migraine prophylaxis and various seizure types. * **Lamotrigine (Option C):** This is a second-line agent for trigeminal neuralgia (often used as an add-on). In psychiatry, it is specifically preferred for the maintenance phase of Bipolar Disorder to prevent depressive episodes. * **Lithium (Option D):** The classic "gold standard" mood stabilizer for Bipolar Affective Disorder (BPAD). It has no role in the management of neuropathic pain or trigeminal neuralgia. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Carbamazepine is the DOC for Trigeminal Neuralgia and Complex Partial Seizures. * **Pharmacokinetics:** It is a potent **enzyme inducer** and exhibits **auto-induction** (it induces its own metabolism). * **Side Effects:** Look for questions on **HLA-B*1502** (risk of Stevens-Johnson Syndrome in Asian populations), SIADH (hyponatremia), and agranulocytosis. * **Alternative:** If Carbamazepine is not tolerated, **Oxcarbazepine** is often preferred due to a better side-effect profile.

Q: Which among the following is not an antipsychotic?

Chlordiazepoxide. **Explanation:** The correct answer is **Chlordiazepoxide** because it belongs to the **Benzodiazepine (BZD)** class of drugs, not antipsychotics. It acts as a sedative-hypnotic and anxiolytic by enhancing the action of GABA at the $GABA_A$ receptor. Clinically, it is most notably used for the management of alcohol withdrawal symptoms and severe anxiety. **Analysis of Options:** * **Risperidone (Option A):** An **Atypical (Second Generation) Antipsychotic**. It acts by blocking both $D_2$ and $5-HT_{2A}$ receptors. It is commonly used for schizophrenia and bipolar disorder. * **Haloperidol (Option B):** A **Typical (First Generation) Antipsychotic** belonging to the Butyrophenone class. It is a potent $D_2$ receptor antagonist known for a high incidence of Extrapyramidal Side Effects (EPS). * **Clozapine (Option D):** The prototype **Atypical Antipsychotic**. It is the "Gold Standard" for **treatment-resistant schizophrenia** but requires mandatory blood monitoring due to the risk of agranulocytosis. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Clozapine is the DOC for resistant schizophrenia and for reducing suicidal behavior in schizophrenic patients. * **Side Effects:** Haloperidol is most likely to cause **Hyperprolactinemia** and **EPS**, whereas Clozapine is least likely to cause EPS but most likely to cause **Sialorrhea** (drooling), weight gain, and seizures. * **Chlordiazepoxide:** Along with Diazepam, it is the preferred agent for preventing seizures and delirium tremens in **Alcohol Withdrawal Syndrome** due to its long half-life.

Q: A 65-year-old male presented to a hospital with focal seizures. His renal function was normal. Which of the following is the drug of choice for this patient?

Oxcarbazepine. **Explanation:** **1. Why Oxcarbazepine is the Correct Answer:** According to the latest clinical guidelines (including ILAE and NICE), **Carbamazepine** [1] and **Oxcarbazepine** [1] are considered the first-line drugs of choice for **focal (partial) seizures** in adults [2]. Oxcarbazepine is often preferred over Carbamazepine because it acts as a prodrug (converted to Licarbazepine) [1], does not form the toxic epoxide metabolite, and is not a potent enzyme inducer (it does not undergo auto-induction). This results in a better side-effect profile and fewer drug-drug interactions. **2. Analysis of Incorrect Options:** * **A. Valproate:** While Valproate is a broad-spectrum anti-epileptic and the drug of choice for generalized tonic-clonic seizures (GTCS) and myoclonic seizures [2], it is generally considered a second-line option for focal seizures due to its side-effect profile (weight gain, hepatotoxicity). * **B. Pregabalin:** This is primarily used as an **adjunctive (add-on) therapy** for focal seizures or for neuropathic pain. It is not recommended as first-line monotherapy. * **C. Levetiracetam:** This is a very common and effective broad-spectrum drug often used in clinical practice. However, in the context of standard pharmacological hierarchy for NEET-PG, Oxcarbazepine/Carbamazepine remains the classic "textbook" first-line choice for focal seizures. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Oxcarbazepine blocks voltage-gated sodium channels [1]. * **Side Effects:** A critical side effect to remember for exams is **Hyponatremia** (more common with Oxcarbazepine than Carbamazepine). * **Drug of Choice Summary:** * Focal Seizures: Oxcarbazepine/Carbamazepine [2]. * Absence Seizures: Ethosuximide. * Myoclonic/Generalized Seizures: Valproate [2]. * Trigeminal Neuralgia: Carbamazepine [1].

Q: Which of the following substances exhibits an increased tendency to promote sleep without causing central nervous system depression?

Melatonin. **Explanation:** **Melatonin** is the correct answer because it is a naturally occurring hormone produced by the pineal gland that regulates the **circadian rhythm** (sleep-wake cycle). Unlike traditional sedatives (like benzodiazepines or barbiturates), melatonin promotes sleep by signaling the "biological night" to the brain via **MT1 and MT2 receptors** in the suprachiasmatic nucleus. It facilitates sleep onset without causing generalized CNS depression, respiratory depression, or significant cognitive impairment. **Analysis of Incorrect Options:** * **Pyridoxine (Vitamin B6):** While it is a cofactor in the synthesis of neurotransmitters like GABA and serotonin, it does not have direct sedative properties. In fact, high doses taken at night may occasionally cause vivid dreams or restlessness. * **Diphenhydramine:** This is a first-generation H1-antihistamine. While it promotes sleep, it does so by crossing the blood-brain barrier and causing **significant CNS depression**, leading to side effects like daytime drowsiness, impaired psychomotor function, and anticholinergic effects. * **Ethanol:** Although it shortens sleep latency, ethanol is a potent **CNS depressant**. It disrupts sleep architecture (reducing REM sleep) and can lead to rebound insomnia and respiratory depression. **NEET-PG High-Yield Pearls:** * **Ramelteon:** A synthetic MT1/MT2 receptor agonist used for insomnia; it has no abuse potential and is not a controlled substance. * **Suvorexant:** An **Orexin receptor antagonist** (Dual Orexin Receptor Antagonist - DORA), another class of sleep aids that promotes sleep by inhibiting wakefulness rather than inducing global CNS depression. * Melatonin is specifically indicated for **Jet Lag** and **Delayed Sleep Phase Disorder**.

Q: Which of the following is a selective 5-HT1B/1D receptor agonist useful in the acute management of migraine?

Frovatriptan. ### Explanation **Correct Answer: C. Frovatriptan** **Mechanism and Rationale:** Triptans (like Frovatriptan, Sumatriptan, and Rizatriptan) are the first-line agents for the **acute management** of moderate-to-severe migraine attacks. They act as selective agonists at **5-HT1B** and **5-HT1D** receptors. * **5-HT1B stimulation** causes vasoconstriction of dilated intracranial extracerebral blood vessels. * **5-HT1D stimulation** acts on trigeminal nerve endings to inhibit the release of pro-inflammatory neuropeptides (like CGRP and Substance P), thereby blocking neurogenic inflammation. **Analysis of Incorrect Options:** * **A. Buspirone:** A selective **5-HT1A partial agonist** used primarily as a non-benzodiazepine anxiolytic for Generalized Anxiety Disorder (GAD). It has no role in migraine management. * **B. Ondansetron:** A **5-HT3 receptor antagonist** used as a potent antiemetic, particularly for chemotherapy-induced nausea and vomiting (CINV). * **D. Ketanserin:** A **5-HT2 receptor antagonist** (with α1-blocking properties) used occasionally as an antihypertensive; it is not used for migraine. **High-Yield NEET-PG Pearls:** * **Longest Half-life:** Frovatriptan has the longest half-life (~26 hours) among all triptans, making it ideal for preventing **menstrual migraine** and reducing recurrence. * **Fastest Acting:** Sumatriptan (SC) or Rizatriptan (Oral). * **Contraindications:** Due to their vasoconstrictive properties, triptans are strictly contraindicated in patients with **Ischemic Heart Disease (IHD)**, Prinzmetal angina, or uncontrolled hypertension. * **Serotonin Syndrome:** Risk increases if triptans are co-administered with SSRIs or MAO inhibitors.

Q: Benzodiazepines exert their effects through which receptor subtype?

GABA-A. **Explanation:** **Benzodiazepines (BZDs)** act as positive allosteric modulators of the **GABA-A receptor**. This receptor is a ligand-gated ionotropic chloride channel. When BZDs bind to a specific site (the BZD site, located between the $\alpha$ and $\gamma$ subunits), they increase the **frequency** of chloride channel opening in response to GABA. This leads to hyperpolarization of the postsynaptic neuron, resulting in CNS depression (anxiolysis, sedation, and anticonvulsant effects). **Analysis of Options:** * **GABA-A (Correct):** It is an **ionotropic** receptor. BZDs increase the frequency of channel opening, while Barbiturates increase the duration. * **GABA-B (Incorrect):** This is a **metabotropic** (G-protein coupled) receptor linked to $K^+$ channels. It is the target for **Baclofen**, a centrally acting muscle relaxant. BZDs have no affinity for this receptor. * **GABA-C (Incorrect):** Now often classified as a subtype of GABA-A ($\rho$ subunits), these are found primarily in the retina and are not the target for standard BZDs. * **GABA-D (Incorrect):** There is no medically recognized GABA-D receptor subtype. **High-Yield Clinical Pearls for NEET-PG:** 1. **Antidote:** **Flumazenil** is a competitive antagonist at the BZD binding site on the GABA-A receptor, used to reverse BZD overdose. 2. **Z-drugs:** Zolpidem, Zaleplon, and Eszopiclone also bind to the GABA-A receptor (specifically the $\alpha_1$ subunit) but are chemically distinct from BZDs. 3. **Mechanism Distinction:** Remember the mnemonic: **"Fre-zzy"** (BZD increases **Fre**quency) and **"Du-bar"** (Barbiturates increase **Du**ration).

Q: What is the mechanism of action of Disulfiram?

Inhibits aldehyde dehydrogenase. ### Explanation **Mechanism of Action:** Disulfiram acts as an **irreversible inhibitor of the enzyme Aldehyde Dehydrogenase (ALDH)**. Under normal conditions, alcohol is metabolized in a two-step process: 1. Alcohol is converted to **Acetaldehyde** by Alcohol Dehydrogenase. 2. Acetaldehyde is converted to **Acetic Acid** (acetate) by Aldehyde Dehydrogenase. By inhibiting ALDH, Disulfiram causes a rapid rise in blood acetaldehyde levels (5–10 times higher than normal) upon alcohol consumption. This leads to the **Disulfiram-Ethanol Reaction (DER)**, characterized by flushing, tachycardia, palpitations, nausea, vomiting, and hypotension. This "aversion therapy" discourages the patient from consuming alcohol. **Analysis of Options:** * **Option A & B:** Disulfiram does not stimulate these enzymes. Stimulation would accelerate alcohol metabolism and prevent the accumulation of toxic intermediates, defeating the purpose of treatment. * **Option D:** While Disulfiram can inhibit Dopamine Beta-Hydroxylase (leading to increased dopamine levels), this is not its primary mechanism for treating alcohol dependence. **High-Yield Clinical Pearls for NEET-PG:** * **Disulfiram-like reaction:** Several other drugs can cause a similar reaction when taken with alcohol. Mnemonic: **"PM Cans"** (**P**rocarbazine, **M**etronidazole, **C**efoperazone/Cefotetan, **A**ntidiabetic sulfonylureas like Chlorpropamide, **N**itrofurantoin, **S**eptrin/TMP-SMX). * **Contraindication:** It should never be administered if the patient has consumed alcohol within the last 12 hours. * **Duration:** The effect lasts for 1–2 weeks after discontinuation because it is an irreversible inhibitor; the body must synthesize new enzymes.

Question 1

Sumatriptan is used in which of the following conditions?

Accepted Answer

Migraine

Answer

Mania

Answer

Depression

Answer

Schizophrenia

Question 2

Which of the following is NOT a feature of morphine withdrawal?

Accepted Answer

Diarrhea

Answer

Piloerection

Answer

Insomnia

Answer

Rhinorrhea

Question 3

Which mood stabilizer is used in the management of trigeminal neuralgia?

Accepted Answer

Carbamazepine

Answer

Valproate

Answer

Lamotrigine

Answer

Lithium

Question 4

A patient was admitted to the emergency department due to alcohol intoxication. 12 Hours after admission, the patient began to show agitation and seizure-like activities. The drug used in treatment acts by:

Accepted Answer

Facilitating GABA by increasing the frequency of chloride channel opening

Answer

Facilitating GABA action by increasing the duration of chloride channel opening

Answer

5-HT antagonist

Answer

5-HT agonist

Question 5

Which among the following is not an antipsychotic?

Accepted Answer

Chlordiazepoxide

Answer

Risperidone

Answer

Haloperidol

Answer

Clozapine

Question 6

A 65-year-old male presented to a hospital with focal seizures. His renal function was normal. Which of the following is the drug of choice for this patient?

Accepted Answer

Oxcarbazepine

Answer

Valproate

Answer

Pregabalin

Answer

Levetiracetam

Question 7

Which of the following substances exhibits an increased tendency to promote sleep without causing central nervous system depression?

Accepted Answer

Melatonin

Answer

Pyridoxine

Answer

Diphenhydramine

Answer

Ethanol

Question 8

Which of the following is a selective 5-HT1B/1D receptor agonist useful in the acute management of migraine?

Accepted Answer

Frovatriptan

Answer

Buspirone

Answer

Ondansetron

Answer

Ketanserin

Question 9

Benzodiazepines exert their effects through which receptor subtype?

Accepted Answer

GABA-A

Answer

GABA-B

Answer

GABA-C

Answer

GABA-D

Question 10

What is the mechanism of action of Disulfiram?

Accepted Answer

Inhibits aldehyde dehydrogenase

Answer

Stimulates alcohol dehydrogenase

Answer

Stimulates aldehyde dehydrogenase

Answer

Inhibits dopamine oxidase

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?